zbMATH — the first resource for mathematics

Modeling the transmission dynamics and control of hepatitis B virus in China. (English) Zbl 1403.92316
Summary: Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV) and is a major global health problem. HBV is the most common serious viral infection and a leading cause of death in mainland China. Around 130 million people in China are carriers of HBV, almost a third of the people infected with HBV worldwide and about 10% of the general population in the country; among them 30 million are chronically infected. Every year, 300,000 people die from HBV-related diseases in China, accounting for 40–50% of HBV-related deaths worldwide. Despite an effective vaccination program for newborn babies since the 1990s, which has reduced chronic HBV infection in children, the incidence of hepatitis B is still increasing in China. We propose a mathematical model to understand the transmission dynamics and prevalence of HBV infection in China. Based on the data reported by the Ministry of Health of China, the model provides an approximate estimate of the basic reproduction number \(R_0=2.406\). This indicates that hepatitis B is endemic in China and is approaching its equilibrium with the current immunization program and control measures. Although China made a great progress in increasing coverage among infants with hepatitis B vaccine, it has a long and hard battle to fight in order to significantly reduce the incidence and eventually eradicate the virus.

92D30 Epidemiology
92C60 Medical epidemiology
Full Text: DOI
[1] Anderson, R.M.; May, R.M., Infectious disease of humans: dynamics and control, (1991), Oxford University Press Oxford
[2] Anderson, R.M.; May, R.M.; Nokes, D.J., Preliminary analyses of the predicted impacts of various vaccination strategies on the transmission of hepatitis B virus, (), 95-130
[3] CGC, 2009. The Central Government of the People’s Republic of China, Guidelines on Deepening the Reform of Health-care System (2009-2011). \(\langle\)http://www.gov.cn/zwgk/2009-04/07/content_1279256.htm〉 (April 7, 2009).
[4] Cui, F.Q.; Wang, X.J.; Liang, X.F., Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese center for disease control and prevention, Chin. J. vaccines immunization, 12, 206-208, (2006)
[5] Diekmann, O.; Heesterbeek, J.A.P.; Metz, J.A.J., On the definition and the computation of the basic reproduction ratio \(R_0\) in models for infectious diseases in heterogeneous populations, J. math. biol., 28, 365-382, (1990) · Zbl 0726.92018
[6] Edmunds, W.J.; Medley, G.F.; Nokes, D.J., The transmission dynamics and control of hepatitis B virus in the gambia, Stat. med., 15, 2215-2233, (1996)
[7] Edmunds, W.J.; Medley, G.F.; Nokes, D.J., Vaccination against hepatitis B virus in highly endemic area: waning vaccine-induced immunity and the need for booster doses, Trans. R. soc. trop. med. hyg., 90, 436-440, (1996)
[8] Edmunds, W.J.; Medley, G.F.; Nokes, D.J.; Hall, A.J.; Whittle, H.C., The influence of age on the development of the hepatitis B carrier state, Proc. R. soc. lond. B, 253, 197-201, (1993)
[9] Edmunds, W.J.; Medley, G.F.; Nokes, D.J.; Hall, A.J.; Whittle, H.C., Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas, Epidemiol. infect., 117, 313-325, (1996)
[10] GAVI. 2009. The Global Alliance for Vaccines and Immunization, China \(\langle\)http://www.gavialliance.org/performance/country_results/index.php?countID=75〉.
[11] Goldstein, S.T.; Zhou, F.J.; Hadler, S.C.; Bell, B.P.; Mast, E.E.; Margolis, H.S., A mathematical model to estimate global hepatitis B disease burden and vaccination impact, Int. J. epidemiol., 34, 1329-1339, (2005)
[12] Hahnea, S.; Ramsaya, M.; Balogun, K.; Edmundsa, W.J.; Mortimer, P., Incidence and routes of transmission of hepatitis B virus in england and wales, 1995-2000: implications for immunisation policy, J. clin. virol., 29, 211-220, (2004)
[13] Hou, J.; Liu, Z.; Gu, F., Epidemiology and prevention of hepatitis B virus infection, Int. J. med. sci., 2, 1, 50-57, (2005)
[14] Hyams, K.C., Risks of chronicity following acute hepatitis B virus infection: a review, Clin. infect. dis., 20, 992-1000, (1995)
[15] Jia, J.D.; Zhuang, H., The overview of the seminar on chronic hepatitis B, Chin. J. hepatol., 12, 698-699, (2004)
[16] Lavanchy, D., Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures, J. viral. hepat., 11, 97-107, (2004)
[17] Liu, G.-T., Comments on the prevention and research of chronic hepatitis in China, Natl. med. J. China, 82, 74-76, (2002)
[18] Locarnini, S., Molecular virology of hepatitis B virus, Semin. liver dis., 24, Suppl. 1, 3-10, (2004)
[19] Maynard, J.E.; Kane, M.A.; Hadler, S.C., Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization, Rev. infect. dis., 2, suppl. 3, S574-S578, (1989)
[20] McLean, A.R.; Blumberg, B.S., Modelling the impact of mass vaccination against hepaitits B. I. model formulation and parameter estimation, Proc. R. soc. lond. B, 256, 7-15, (1994)
[21] Medley, G.F.; Lindop, N.A.; Edmunds, W.J.; Nokes, D.J., Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control, Nat. med., 7, 5, 619-624, (2001)
[22] MOHC, 2009. Ministry of Health of the People’s Republic of China. \(\langle\)http://www.moh.gov.cn/publicfiles//business/htmlfiles/zwgkzt/pyq/list.htm〉.
[23] MMWR, 2007. Progress in hepatitis B prevention through universal infant vaccination—China 1997-2006. Morbidity Mortality Weekly Rep. 56 (18), 441-445.
[24] Shepard, C.W.; Simard, E.P.; Finelli, L.; Fiore, A.E.; Bell, B.P., Hepatitis B virus infection: epidemiology and vaccination, Epidemiol. rev., 28, 112-125, (2006)
[25] Sun, Z.T., A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine, (), 83-90
[26] Sun, Z.T.; Ming, L.H.; Zhu, X.; Lu, J.H., Prevention and control of hepatitis B in China, J. med. virol., 67, 447-450, (2002)
[27] Thornley, S.; Bullen, C.; Roberts, M., Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy, J. theor. biol., 254, 599-603, (2008) · Zbl 1400.92543
[28] van den Driessche, P.; Watmough, J., Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. biosci., 180, 29-48, (2002) · Zbl 1015.92036
[29] Wang, X.J.; Zhang, R.Z.; Hu, Y.S.; Liang, X.F., Analysis on epidemic status of viral hepatitis in China: the report from Chinese center for disease control and prevention, Dis. surveillance, 19, 290-292, (2004)
[30] WHO, 2008. Hepatitis B. \(\langle\)http://www.who.int/mediacentre/factsheets/fs204/en/index.html〉 (revised August 2008).
[31] Williams, R., Global challenges in liver disease, Hepatol., 44, 3, 521-526, (2006)
[32] Williams, J.R.; Nokes, D.J.; Medley, G.F.; Anderson, R.M., The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes, Epidemiol. infect., 116, 71-89, (1996)
[33] Zhao, S.-J.; Xu, Z.-Y.; Lu, Y., A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China, Int. J. epidemiol., 29, 744-752, (2000)
[34] Zuckerman, A.J.; Sun, T.-T.; Linsell, A.; Stjernsward, J., Prevention of primary liver cancer, Lancet, 1, 463-465, (1983)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. It attempts to reflect the references listed in the original paper as accurately as possible without claiming the completeness or perfect precision of the matching.